Phospho-Insulin Receptor (Tyr1185) Antibody [D6L11]

N. catalogo F3837

Stampa

Descrizione biologica

Specificità Phospho-Insulin Receptor (Tyr1185) Antibody [D6L11] rileva i livelli endogeni della proteina del recettore dell'insulina solo quando fosforilata a Tyr 1185.
Contesto Il recettore dell'insulina (IR) è una Protein Tyrosine Kinase cruciale per mediare gli effetti pleiotropici dell'insulina sul metabolismo e sulla crescita. Il suo dominio chinasico intracellulare contiene un anello di attivazione (anello A) con residui chiave di tirosina, Tyr1158, Tyr1162 e Tyr1163, la cui fosforilazione innesca cambiamenti conformazionali che attivano completamente la chinasi. La fosforilazione di Tyr1185 stabilizza la conformazione attiva dell'anello A, consentendo un accesso illimitato all'ATP e ai peptidi substrato, permettendo così un'efficiente fosforilazione del substrato. Questa autofosforilazione è un processo graduale in cui ogni tirosina fosforilata stabilizza incrementalmente la conformazione attiva garantendo una stretta regolazione. Il gruppo fosfato su Tyr1185 funge da interruttore molecolare critico, promuovendo riarrangiamenti strutturali che fanno passare la chinasi da uno stato auto-inibito a uno stato attivo. Le tirosine fosforilate dell'anello A, inclusa Tyr1185, creano siti di aggancio per proteine di segnalazione a valle come IRS (substrato del recettore dell'insulina), integrando l'attivazione del recettore con le vie cellulari tra cui le cascate PI3K/Akt e MAPK che regolano l'assorbimento del glucosio, il metabolismo e l'espressione genica. La disregolazione della fosforilazione dell'IR compromette la segnalazione dell'insulina ed è implicata nell'insulino-resistenza e nel diabete di tipo 2.

Informazioni sullutilizzo

Applicazione WB, IP Diluizione
WB IP
1:2000 1:20
Reattività Human
Fonte Rabbit Monoclonal Antibody MW 156 kDa
Tampone di conservazione PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Conservazione
(Dalla data di ricevimento)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:2000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Riferimenti

  • https://pubmed.ncbi.nlm.nih.gov/37001136/
  • https://pubmed.ncbi.nlm.nih.gov/9312016/

Dati di applicazione

WB

Validato da Selleck

  • F3837-wb
    Lane 1: HepG2, Lane 2: HepG2 (Insulin treated)